Taliaz
PREDICTIX — AI clinical decision-support for mental health: antidepressant selection (pharmacogenetic) + triage/care management
Latest event found: 28 Apr 2025 · over 1 year ago · nothing in the last 12 months
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
Taliaz is pursuing AI-enabled precision psychiatry through pharmacogenetic prescribing, digital triage, and clinical workflow products, with commercialization centered on partnerships in Israel and Europe. Public evidence indicates continued platform activity but limited proof of broad revenue scale or rapid organizational expansion.
Efficiency Ratio
The company appears capital- and headcount-efficient, converting a small team and grant-oriented funding base into multiple pilots and partnerships, although independently verified commercial output remains modest.
Evidence Signals
Background · older than 12 months
Dekel Taliaz and Oren Taliaz were appointed directors of Taliaz Ltd, a UK-registered entity.
Taliaz partnered with Psychiatry UK to deliver AI-driven genetic testing intended to support antidepressant selection for depression patients.
Taliaz received a $2.7 million grant from the European Union Horizon 2020 program to expand clinical research on its PREDICTIX products.
Cerba and Taliaz announced a partnership to apply AI and genetics capabilities to depression care management and personalized treatment.
Grounded Research at RDaSH NHS Foundation Trust announced a collaboration with Taliaz to improve mental-health care in the UK.
- About
- Israeli behavioral-health AI company (HQ Petah Tikva, Israel; founded ~2015 by neuroscientist brothers Dr. Dekel Taliaz (CEO) and Oren Taliaz). Its PREDICTIX platform is a clinical decision-support tool for mental health: PREDICTIX Antidepressant uses AI over genetic, clinical and demographic data to help clinicians pick the right antidepressant first time (CE-registered; commercial in EU and Israel), and PREDICTIX Care adds AI-driven patient triage, intake, queue/resource management and automated note-taking — cutting mental-health backlog by up to ~75%. Traction includes an Israel Ministry of Health agreement (~$8M) with Maccabi HMO, plus UK (Psychiatry UK) and France (Cerba HealthCare). Defense relevance: the triage/queue-management tooling has been used to cut waiting lists in Israel's trauma centers amid the post-2023 reservist mental-health surge; center of gravity is behavioral-health decision-support software, not a treatment device.
- Tags
- #behavioralhealth #mentalhealth #ai #pharmacogenetics #predictix #decisionsupport #triage #depression #antidepressant #dualuse